ALX3
Basic information
Region (hg38): 1:110059870-110070672
Previous symbols: [ "FND" ]
Links
Phenotypes
GenCC
Source:
- frontorhiny (Definitive), mode of inheritance: AR
- frontorhiny (Strong), mode of inheritance: AR
- frontorhiny (Supportive), mode of inheritance: AR
- frontorhiny (Strong), mode of inheritance: AR
- frontorhiny (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Frontonasal dysplasia 1 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic | 17963218; 19409524; 22106187 |
ClinVar
This is a list of variants' phenotypes submitted to
- Frontorhiny (1 variants)
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ALX3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 10 | |||||
missense | 34 | 36 | ||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 6 | |||||
Total | 2 | 1 | 35 | 10 | 8 |
Variants in ALX3
This is a list of pathogenic ClinVar variants found in the ALX3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-110060664-A-AGGTGCTTCCTCCGTGGTGTCCAGGCAGG | Benign (Nov 10, 2018) | |||
1-110060761-G-A | Inborn genetic diseases | Uncertain significance (Mar 28, 2023) | ||
1-110060767-T-G | Inborn genetic diseases | Uncertain significance (Apr 18, 2023) | ||
1-110060772-C-G | Inborn genetic diseases | Uncertain significance (Aug 10, 2023) | ||
1-110060777-C-T | Inborn genetic diseases | Uncertain significance (Feb 05, 2024) | ||
1-110060778-C-G | Inborn genetic diseases | Uncertain significance (Mar 20, 2024) | ||
1-110060790-G-A | ALX3-related disorder | Likely benign (Jun 28, 2019) | ||
1-110060806-T-C | Inborn genetic diseases | Uncertain significance (Jan 24, 2024) | ||
1-110060850-G-A | Benign (Nov 15, 2023) | |||
1-110060878-C-T | Inborn genetic diseases | Uncertain significance (Jul 14, 2024) | ||
1-110060889-C-T | Likely benign (Oct 08, 2022) | |||
1-110060896-G-C | Inborn genetic diseases | Uncertain significance (Oct 30, 2024) | ||
1-110060903-G-A | Inborn genetic diseases | Uncertain significance (Nov 04, 2020) | ||
1-110060987-G-A | Inborn genetic diseases | Uncertain significance (Jun 18, 2021) | ||
1-110061016-G-A | Inborn genetic diseases | Uncertain significance (Aug 04, 2024) | ||
1-110061017-G-C | not specified | Benign/Likely benign (Nov 01, 2024) | ||
1-110061027-CAG-C | Frontorhiny | Likely pathogenic (Aug 03, 2016) | ||
1-110061454-C-T | Inborn genetic diseases | Uncertain significance (Apr 29, 2021) | ||
1-110061464-C-T | Inborn genetic diseases | Uncertain significance (Oct 29, 2021) | ||
1-110061469-A-C | Inborn genetic diseases | Uncertain significance (Apr 09, 2024) | ||
1-110061475-T-C | Inborn genetic diseases | Uncertain significance (Jul 14, 2022) | ||
1-110061496-C-T | Inborn genetic diseases • Frontorhiny | Conflicting classifications of pathogenicity (Jun 27, 2024) | ||
1-110061516-A-G | Likely benign (Mar 29, 2018) | |||
1-110061527-G-T | Inborn genetic diseases | Uncertain significance (Jan 03, 2024) | ||
1-110061531-C-T | not specified | Benign/Likely benign (Dec 31, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ALX3 | protein_coding | protein_coding | ENST00000369792 | 4 | 10707 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0191 | 0.907 | 125740 | 0 | 7 | 125747 | 0.0000278 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.446 | 151 | 167 | 0.903 | 0.0000103 | 2178 |
Missense in Polyphen | 54 | 78.396 | 0.68881 | 805 | ||
Synonymous | 0.475 | 63 | 68.0 | 0.927 | 0.00000385 | 752 |
Loss of Function | 1.51 | 4 | 8.87 | 0.451 | 4.64e-7 | 122 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000905 | 0.0000905 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000355 | 0.0000352 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional regulator with a possible role in patterning of mesoderm during development. {ECO:0000250}.;
- Disease
- DISEASE: Frontonasal dysplasia 1 (FND1) [MIM:136760]: The term frontonasal dysplasia describes an array of abnormalities affecting the eyes, forehead and nose and linked to midfacial dysraphia. The clinical picture is highly variable. Major findings include true ocular hypertelorism; broadening of the nasal root; median facial cleft affecting the nose and/or upper lip and palate; unilateral or bilateral clefting of the alae nasi; lack of formation of the nasal tip; anterior cranium bifidum occultum; a V-shaped or widow's peak frontal hairline. {ECO:0000269|PubMed:19409524}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.0999
Intolerance Scores
- loftool
- 0.150
- rvis_EVS
- -0.25
- rvis_percentile_EVS
- 35.75
Haploinsufficiency Scores
- pHI
- 0.521
- hipred
- N
- hipred_score
- 0.410
- ghis
- 0.626
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.467
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Alx3
- Phenotype
- craniofacial phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; skeleton phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; embryo phenotype;
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II;pattern specification process;embryonic forelimb morphogenesis;embryonic hindlimb morphogenesis;regulation of apoptotic process;embryonic cranial skeleton morphogenesis
- Cellular component
- nucleus
- Molecular function
- RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;sequence-specific DNA binding